Clinical Trials Logo

Complex Partial Seizures clinical trials

View clinical trials related to Complex Partial Seizures.

Filter by:
  • None
  • Page 1

NCT ID: NCT01749046 Completed - Epilepsy Clinical Trials

Remegal Fixed Dose as Adjunctive Therapy in Patients With Partial Seizures

Start date: March 2012
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine weather Remegal in fixed dosage 1500 mg/daily is effictive and safe in patients with epilepsy with partial seizures

NCT ID: NCT01648959 Terminated - Clinical trials for Complex Partial Seizures

Intra Cranial EEG Activity During Dexmedetomidine Sedation

Start date: July 2012
Phase:
Study type: Observational

Various parts of the brain are sensitive to various anesthetics.We like to study the effect of dexmedetomidine on the different parts of the brain in patients who are coming for DBS electrode removal under sedation.

NCT ID: NCT01266291 Terminated - Clinical trials for Complex Partial Seizures

Sabril for Complex Partial Seizures in Adult Tolerability Study (TS) Patients

STARS: TS
Start date: August 2010
Phase: Phase 4
Study type: Interventional

This is an open-label, phase 4 study to examine the safety and efficacy of vigabatrin (Sabril) in Tuberous Sclerosis patients, a subset of the larger refractory complex partial epilepsy population for which the drug is approved. While enrolled on this trial, subjects will continue to take all of their normally prescribed medications, including their other antiepileptic drugs (AEDs). Alternatively, there is a prospective observational arm that subjects who are about to take Sabril as treatment for seizures associated with Tuberous Sclerosis may join. Subjects who join this arm will not have any study visits and will not be asked to do anything specifically for the study. The study team will collect all study data from subjects' medical records only.

NCT ID: NCT00991757 Completed - Epilepsy Clinical Trials

An Open-Label Extension Study to Evaluate the Safety and Tolerability of RWJ 333369 as Adjunctive Therapy in Patients 16 Years and Older With Partial Onset Seizures.

Start date: February 2007
Phase: Phase 3
Study type: Interventional

The purpose of this open-label extension study is to demonstrate that RWJ-333369 is safe as long-term add-on treatment of partial onset seizures.

NCT ID: NCT00433667 Completed - Epilepsy Clinical Trials

A Study of the Efficacy and Safety of RWJ-333369 as add-on Therapy in the Treatment of Partial Onset Seizures.

Start date: November 2006
Phase: Phase 3
Study type: Interventional

The purpose of this study is to demonstrate that RWJ-333369 is safe and effective as add-on treatment of partial onset seizures.

NCT ID: NCT00425282 Completed - Epilepsy Clinical Trials

A Study of the Efficacy and Safety of RWJ-333369 as add-on Therapy in the Treatment of Partial Onset Seizures.

Start date: November 2006
Phase: Phase 3
Study type: Interventional

The purpose of this study is to demonstrate that RWJ-333369 is safe and effective as add-on treatment of partial onset seizures.